Abstract
Idiopathic intracranial hypertension (IIH) is characterized by symptoms and signs of elevated intracranial pressure, elevated cerebrospinal fluid (CSF) pressure, normal CSF content, and normal brain with normal or small ventricles on neuroimaging studies. IIH in children has a wide spectrum of clinical presentation. Diagnostic criteria with modifications to adapt to the variations in children are discussed. Diagnostic and therapeutic options are reviewed.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Quincke H. Uber meningitis serora and verewandte zustande. Dtsch Z Nervenheil. 1897;9:149–68.
Nonne M. Ueber Falle vom Symptomkomplex “tumor cerebri” mit Ausgang in Heilung. Dtsch Z Nervenheil. 1904;27:169–216.
Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg. 1937;106:492–513.
Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol. 1988;45:875–7.
Balcer LJ, Liu GT, Forman S, Pun K, Volpe NJ, Galletta SL et al. Idiopathic intracranial hypertension: relationship of age and obesity in children. Neurology. 1999;52:870–2.
Binder DK, Horton HC, Lawton MT, McDermott MW. Idiopathic intracranial hypertension. Neurosurgery. 2004;54:538–52.
Spennato P, Ruggiero C, Parlato RS, Buonocore MC, Varone A, Cianciuli E et al. Pseudotumor cerebri. Childs Nerv Syst. 2011;27:215–35.
Babikian P, Corbett J, Bell W. Idiopathic intracranial hypertension in children: the Iowa experience. J Child Neurol. 1994;9:144–9.
Phillips PH, Repka MX, Lambert SR. Pseudotumor cerebri in children. JAAPOS. 1998;2:33–8.
Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol. 2007;52:597–617.
Phillips PH. Pediatric pseudotumor cerebri. Int Ophthalmol Clin. 2012;3:51–9.
Friedman DI. Idiopathic intracranial hypertension. Curr Pain Headache Rep. 2007;11:62–8.
Tibussek D, Schneider DT, Vandemeulebroecke N, Turowski B, Messing-Juenger M, Wilems P et al. Clinical spectrum of the pseudotumor cerebri complex in children. Childs Nerv Syst. 2010;26:313–21.
Per H, Canpolat M, Gumus H, Poyrazoglu HG, Yikilmaz A, Karakucuk S et al. Clinical spectrum of pseudotumor cerebri in children: etiological, clinical features, treatment and prognosis. Brain Dev. 2012 (in press).
Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol. 2002;17:745–8.
Eldes NH, Yilmaz Y. Pseudotumor cerebri in children: etiological, clinical features, and treatment modalities. Eur J Paediatr Neurol. 2012;16:349–55.
Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol. 1999;127:178–82.
Bassan H, Berkner L. Asymptomatic idiopathic intracranial hypertension in children. Acta Neurol Scand. 2008;118:251–5.
Tan H. Bilateral oculomotor palsy secondary to pseudotumor cerebri. Pediatr Neurol. 2010;42:141–2.
Tzoufi M, Makis A, Grammeniatis V, Nakou I, Exarchakos G, Asproudis I et al. Idiopathic intracranial hypertension and facial palsy: case report and review of literature. J Child Neurol. 2010;25:1529–34.
Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59:1492–5.
• Avery RA, Shah SS, Licht DJ, Seiden JA, Huh JW, Boswinkel J et al. Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med. 2010;363:891–3. This 2 year single-center perspective study of CSF opening pressure in children undergoing lumbar puncture had systematically defined reference range for CSF pressure in pediatric population. It suggested that an opening pressure of >280 mm H20 should be considered elevated in this age group.
•• Avery RA, Licht DJ, Shah SS, Huh JW, Seiden JA, Boswinkel J et al. CSF opening pressure in children with optic nerve head edema. Neurology. 2011;76:1658–61. This is a prospective comparative study that evaluated the range of opening pressure for children with optic nerve head edema and age-matched controls. It re-affirms the finding that an opening pressure of >280 mm H20 in children is abnormal. This also serves a basis to reconsider the diagnostic criteria for IIH pediatric age.
Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. Cephalalgia. 2004;24:9–160.
Lim MJ, Pushparajah K, Jan W, Calver D, Lin JP. Magnetic resonance imaging changes in idiopathic intracranial hypertension in children. J Child Neurol. 2010;25:294–9.
Shofty B, Ben-Sira L, Constantini S, Freedman S, Kesler A. Optic nerve sheath diameter on MR Imaging: establishment of norms and comparison of pediatric patients with idiopathic intracranial hypertension with healthy controls. Am J Neuroradiol. 2012;33:366–9.
Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2012;83:488–94.
Ahmed R, Friedman DI, Halmagyi GM. Stenting of the tranverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol. 2011;66:334–8.
Stienen A, Weinzierl M, Ludolph A, Tibussek D, Hausler M. Obstruction of the cerebral venous sinus secondary to idiopathic intracranial hypertension. Eur J Neurol. 2008;15:1416–8.
Standbridge SM, O’Brien SH. Idiopathic intracranial hypertension in a pediatric population: a retrospective analysis of the initial imaging evaluation. J Child Neurol. 2008;23:1308–11.
Standbridge SM. Idiopathic intracranial hypertension in children: a review and algorithm. Pediatr Neurol. 2010;43:377–90.
Lee MW, Vedanarayanan VV. Cerebrospinal fluid opening pressure in children: experience in a controlled setting. Pediatr Neurol. 2011;45:238–40.
Warden KF, Alizai AM, Trobe JD, Hoff JT. Short term continuous intraparenchymal intracranial pressure monitoring in presumed idiopathic intracranial hypertension. J Neurol Ophthalmol. 2011;32:202–5.
Toma AK, Tarnaris A, Kitchen ND, Watkins LD. Continuous intracranial pressure monitoring in pseudotumour cerebri: single center experience. Br J Neurosurg. 2010;24:584–8.
Avery RA, Mistry RD, Shah SS, Boswinkel J, Huh JW, Ruppe MD et al. Patient position during lumbar puncture has no meaningful effect on cerebrospinal fluid opening pressure in children. J Child Neurol. 2010;25:616–9.
Chern JJ, Tubbs RS, Gordon AS, Donnithorne KJ, Oakes WJ. Management of pediatric patients with pseudotumor cerebri. Child Nerv Syst. 2012;28:575–8.
Wolf A, Hutcheson KA. Advances in evaluation and management of pediatric idiopathic hypertension. Curr Opin Ophthalmol. 2008;19:391–7.
Ball AK, Howman A, Wheatley K, Burdon MA, Matthews T, Jacks AS et al. A randomized controlled trial of treatment for idiopathic intracranial hypertension. J Neurol. 2011;258:874–81.
Matthews YY. Drugs used in childhood idiopathic or benign intracranial hypertension. Arch Dis Child Educ Pract Ed. 2008;93:19–25.
Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116:322–7.
Thuente DD, Buckley EG. Pediatric optic nerve sheath decompression. Ophthalmology. 2005;112:724–7.
Lee AG, Patrinely JR, Edmond JC. Optic nerve sheath decompression in pediatric pseudotumor cerebri. Ophthalmis Surg Lasers. 1998;29:514–7.
Koc K, Anik I. Endoscopic optic nerve decompression for idiopathic intracranial hypertension in 2 cases: case report. Minim Invas Neurosurg. 2008;51:72–5.
Yazici Z, Yazici B, Tuncel E. Findings of magnetic resonance imaging after optic nerve sheath decompression in patients with idiopathic intracranial hypertension. Am J Ophthalmol. 2007;144:429–35.
Kandasamy J, Hayhurst C, Clark S, Jenkinson MD, Byrne P, Karabatsou K et al. Electromagnetic stereotactic ventriculoperitoneal CSF shunting for idiopathic intracranial hypertension: a successful step forward? World Neurosurg. 2011;75:155–60.
Tarnaris A, Toma AK, Watkins LD, Kitchen ND. Is there a difference in outcomes of patients with idiopathic intracranial hypertension with the choice of cerebrospinal fluid diversion site? A single center experience. Clin Neurol Neurosurg. 2011;113:477–9.
Abubaker K, Ali Z, Raza K, Bolger C, Rawluk D, O’Brien D. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts- case series and literature review. Br J Neurosurg. 2011;25:94–9.
Sinclair AJ, Kuruvath S, Sen D, Nightingale PG, Burdon MA, Flint G. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10 year review. Cephalalgia. 2011;31:1627–33.
Ahmed RM, Wilkinson M, Parker GD, Thurtell MJ, Macdonald J, McCluskey PJ et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR. 2011;32:1408–14.
Kumpe DA, Bennett JL, Seinfeld J, Pelak VS, Chawla A, Tierney M. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg. 2012;116:538–48.
Albuquerque FC, Dashti SR, Hu YC, Newman CB, Teleb M, McDougall CG et al. Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results. World Neurosurg. 2011;75:648–52.
Bussiere M, Falero R, Nicolle D, Proulx A, Patel V, Pelz D. Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. AJNR. 2010;31:645–50.
Rajpal S, Niemann DB, Turk AS. Transverse venous sinus stent placement as treatment for benign intracranial hypertension in a young male. J Neurosurg. 2005;102:342–6.
Curry WT, Butler WE, Barker FG. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the US, 1988–2002. Neurosurgery. 2005;57:97–107.
Yri HM, Wegener M, Sander B, Jensen R. Idiopathic intracranial hypertension is not benign: a long-term outcome study. J Neurol. 2012;259:886–94.
Stiebel-Kalish H, Kalish Y, Lusky M, Gaton DD, Ehrlich R, Shuper A. Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension. Am J Ophthalmol. 2006;142:279–83.
Soiberman U, Stolovitch C, Balcer LJ, Regenbogen M, Constantini S, Kesler A. Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Childs Nerv Syst. 2011;27:1913–8.
Kesler A, Hadayer A, Goldhammer Y, Almoq Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology. 2004;63:1737–9.
De Simone R, Marano E, Nilo L, Briganti F, Esposito M, Ripa P. Idiopathic intracranial hypertension without headache. Cephalagia. 2006;26:1020–1.
Wang SJ, Silberstein SD, Patterson S, Young WB. Idiopathic intracranial hypertension without papilledema: a case-control study in a headache center. Neurology. 1998;51:245–9.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Headache
Rights and permissions
About this article
Cite this article
Victorio, M.C., Rothner, A.D. Diagnosis and Treatment of Idiopathic Intracranial Hypertension (IIH) in Children and Adolescents. Curr Neurol Neurosci Rep 13, 336 (2013). https://doi.org/10.1007/s11910-012-0336-x
Published:
DOI: https://doi.org/10.1007/s11910-012-0336-x